Home | Welcome to Contract Pharma   
Last Updated Friday, October 31 2014
Print

Breaking News

June 10, 2014
Phase I study triggers $15M payment   Read More »
June 10, 2014
Meline to head finance and investor relations operations  Read More »
June 10, 2014
Gains Phase I immunotherapy candidate and platform technologies  Read More »
June 10, 2014
Expands services for European markets  Read More »
June 9, 2014
Anicetti brings 30+ years of quality and regulatory experience  Read More »
June 9, 2014
Gains three clinical HCV candidates  Read More »
June 5, 2014
Will share R&D rights to gene editing technology  Read More »
June 5, 2014
inVentiv to launch Aprecia brand and technology platform  Read More »
June 5, 2014
Aims to speed drug development  Read More »
June 4, 2014
Shire invests $20.4 million in arGEN-X  Read More »
June 4, 2014
Will continue to explore new approaches in metabolic disease  Read More »
June 4, 2014
Appoints Dr. Chong to head operations  Read More »
June 3, 2014
Will encompass a broader range of integrated service offerings  Read More »
June 3, 2014
Expands biotech assets in pain care franchise  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On